VistaGen Therapeutics
VTGN
VTGN
54 hedge funds and large institutions have $44.9M invested in VistaGen Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $45.3M → $44.9M (-$422K)
81% less call options, than puts
Call options by funds: $315K | Put options by funds: $1.62M
Holders
54
Holding in Top 10
–
Calls
$315K
Puts
$1.62M
Top Buyers
| 1 | +$2.28M | |
| 2 | +$1.37M | |
| 3 | +$1.23M | |
| 4 |
AC
Almitas Capital
Santa Monica,
California
|
+$751K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$670K |
Top Sellers
| 1 | -$6.02M | |
| 2 | -$2.03M | |
| 3 | -$969K | |
| 4 |
Renaissance Technologies
New York
|
-$315K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$123K |